Table 2 Association of urinary iodine with elevation of UACR and reduction of eGFR

 Prevalence,%

24.4

27.5

24.6

24.2

  Model 1

1.0 (Ref.)

1.17 (1.02–1.36)*

1.01 (0.80–1.28)

0.99 (0.74–1.32)

  Model 2

1.0 (Ref.)

1.17 (1.01–1.38)*

0.95 (0.73–1.23)

0.97 (0.70–1.34)

 Prevalence, %

4.9

6.5

3.3

7.8

  Model 1

1.0 (Ref.)

1.35 (1.03–1.79)*

0.67 (0.38–1.16)

1.67 (1.03–2.70)*

  Model 2

1.0 (Ref.)

1.17 (0.86–1.58)

0.67 (0.36–1.22)

1.48 (0.85–2.58)

 Prevalence, %

26.2

29.8

26.2

28.5

  Model 1

1.0 (Ref.)

1.19 (1.04–1.37)*

1.00 (0.79–1.26)

1.12 (0.85–1.48)

  Model 2

1.0 (Ref.)

1.17 (1.01–1.37)*

0.93 (0.72–1.21)

1.13 (0.83–1.54)